<--- Back to Details
First PageDocument Content
Medicine / Clinical medicine / Microbiology / Cyclopropanes / Healthcare-associated infections / Infectious causes of cancer / Cytokines / Breakthrough therapy / Hepatitis C / Hepatitis / Ribavirin / Interferon
Date: 2016-03-03 12:17:00
Medicine
Clinical medicine
Microbiology
Cyclopropanes
Healthcare-associated infections
Infectious causes of cancer
Cytokines
Breakthrough therapy
Hepatitis C
Hepatitis
Ribavirin
Interferon

Microsoft PowerPoint - Poster EASL 08 IDU MD.ppt

Add to Reading List

Source URL: www.arud.ch

Download Document from Source Website

File Size: 58,57 KB

Share Document on Facebook

Similar Documents

Breakthrough Cancer Therapy DTC

DocID: 1sYyU - View Document

Health / Medicine / Breakthrough therapy / Specialty drugs / Gilead Sciences / Healthcare-associated infections / Cyclopropanes / Sofosbuvir / Ledipasvir / National Institute for Health and Care Excellence / Hepatitis / National Health Service

Microsoft Word - GILEAD BRIEFING

DocID: 1r2Vm - View Document

Breakthrough therapy / Chemistry / Pharmaceutical sciences / Carbamates / Pharmacology / Pyrrolidines / Ombitasvir/paritaprevir/ritonavir / Ritonavir / Ombitasvir / AbbVie Inc. / Paritaprevir / Kidney

Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio

DocID: 1qWZQ - View Document

Clinical medicine / Medicine / Antineoplastic drugs / Breakthrough therapy / Pharmacology / Bristol-Myers Squibb / Monoclonal antibodies / Immune system / Programmed cell death protein 1 / Nivolumab / Pharmac / Pembrolizumab

24 MayDanae Staples-Moon Therapeutic Group Manager PHARMAC PO Box

DocID: 1qVSm - View Document

Clinical medicine / Breakthrough therapy / Pembrolizumab / Medicine

12-AUG:10 CANCER CONTROL ACCRUAL REPORT STUDY O

DocID: 1qRuM - View Document